Endogenous β-adrenergic receptors inhibit lipopolysaccharide-induced pulmonary cytokine release and coagulation

American Journal of Respiratory Cell and Molecular Biology

Volumn 39, Issue 3, 2008, Pages 373-379

  Giebelen, Ida A J ^a   Leendertse, Masja ^a   Dessing, Mark C ^a   Meijers, Joost C M ^a   Levi, Marcel ^a   Draing, Christian ^b   Von Aulock, Sonja ^b   Van Der Poll, Tom ^a,c  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY OF KONSTANZ   (Germany)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

receptor antagonist; Coagulation; Lipopolysaccharide; Lipoteichoic acid; Lung inflammation; Murine model

Indexed keywords

BETA ADRENERGIC RECEPTOR; CHEMOKINE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID; MONOCYTE CHEMOTACTIC PROTEIN 1; PROPRANOLOL; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYTOKINE; TEICHOIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL CELL WALL; BLOOD CLOTTING; CONTROLLED STUDY; CYTOKINE RELEASE; LUNG LAVAGE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PNEUMONIA; PROTEIN FUNCTION; ANIMAL; BACTERIAL PNEUMONIA; C57BL MOUSE; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; FEMALE; IMMUNOLOGY; INHALATIONAL DRUG ADMINISTRATION; LUNG; METABOLISM; PHYSIOLOGY;

BACTERIA (MICROORGANISMS); MURINAE; MUS; NEGIBACTERIA; POSIBACTERIA;

ADMINISTRATION, INHALATION; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BLOOD COAGULATION; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; LIPOPOLYSACCHARIDES; LUNG; MICE; MICE, INBRED C57BL; NEUTROPHILS; PNEUMONIA, BACTERIAL; PROPRANOLOL; RECEPTORS, ADRENERGIC, BETA-2; TEICHOIC ACIDS;

EID: 51249092664     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2007-0439OC     Document Type: Article

References (40)

1. Svedmyr N. The current place of beta 2-agonists in the management of asthma. Lung 1990;168:105-110.
2. Barnes PJ. Effect of beta-agonists on inflammatory cells. J Allergy Clin Immunol 1999;104:10-17.
3. Maris NA, Florquin S, van't Veer C, de Vos AF, Buurman W, Jansen HM, van der Poll T. Inhalation of beta 2 agonists impairs the clearance of nontypable Haemophilus influenzae from the murine respiratory tract. Respir Res 2006;7:57.
4. Johnson M, Rennard S. Alternative mechanisms for long-acting beta(2)-adrenergic agonists in COPD. Chest 2001;120:258-270.
5. Maris NA, van der Sluijs KF, Florquin S, de Vos AF, Pater JM, Jansen HM, van der Poll T. Salmeterol, a beta2-receptor agonist, attenuates lipopolysaccharide-induced lung inflammation in mice. Am J Physiol Lung Cell Mol Physiol 2004;286:1122-1128.
6. Maris NA, de Vos AF, Dessing MC, Spek CA, Lutter R, Jansen HM, van der Zee JS, Bresser P, van der Poll T. Antiinflammatory effects of salmeterol after inhalation of lipopolysaccharide by healthy volunteers. Am J Respir Crit Care Med 2005;172:878-884.
7. Le Tulzo Y, Shenkar R, Kaneko D, Moine P, Fantuzzi G, Dinarello CA, Abraham E. Hemorrhage increases cytokine expression in lung mononuclear cells in mice: involvement of catecholamines in nuclear factor-kappab regulation and cytokine expression. J Clin Invest 1997;99:1516-1524.
8. Su X, Robriquet L, Folkesson HG, Matthay MA. Protective effect of endogenous beta-adrenergic tone on lung fluid balance in acute bacterial pneumonia in mice. Am J Physiol Lung Cell Mol Physiol 2006;290:L769-L776.
9. Eisner MD, Thompson T, Hudson LD, Luce JM, Hayden D, Schoenfeld D, Matthay MA. Efficacy of low tidal volume ventilation in patients with different clinical risk factors for acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med 2001;164:231-236.
10. Bartlett JG, Dowell SF, Mandell LA, File TM Jr, Musher DM, Fine MJ. Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis 2000;31:347-382.
11. Beutler B, Rietschel ET. Innate immune sensing and its roots: the story of endotoxin. Nat Rev Immunol 2003;3:169-176.
12. Ginsburg I. Role of lipoteichoic acid in infection and inflammation. Lancet Infect Dis 2002;2:171-179.
13. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006;124:783-801.
14. Beutler B, Jiang Z, Georgel P, Crozat K, Croker B, Rutschmann S, Du X, Hoebe K. Genetic analysis of host resistance: toll-like receptor signaling and immunity at large. Annu Rev Immunol 2006;24:353-389.
15. Leemans JC, Vervoordeldonk MJ, Florquin S, van Kessel KP, van der Poll T. Differential role of interleukin-6 in lung inflammation induced by lipoteichoic acid and peptidoglycan from Staphylococcus aureus. Am J Respir Crit Care Med 2002;165:1445-1450.
16. Rijneveld AW, Weijer S, Florquin S, Esmon CT, Meijers JC, Speelman P, Reitsma PH, ten Cate H, van der Poll T. Thrombomodulin mutant mice with a strongly reduced capacity to generate activated protein C have an unaltered pulmonary immune response to respiratory pathogens and lipopolysaccharide. Blood 2004;103:1702-1709.
17. Knapp S, Florquin S, Golenbock DT, van der Poll T. Pulmonary lipopolysaccharide (LPS)-binding protein inhibits the LPS-induced lung inflammation in vivo. J Immunol 2006;176:3189-3195.
18. von Aulock S, Morath S, Hareng L, Knapp S, van Kessel KP, van Strijp JA, Hartung T. Lipoteichoic acid from Staphylococcus aureus is a potent stimulus for neutrophil recruitment. Immunobiology 2003;208:413-422.
19. Ueno H, Matsuda T, Hashimoto S, Amaya F, Kitamura Y, Tanaka M, Kobayashi A, Maruyama I, Yamada S, Hasegawa N, et al. Contributions of high mobility group box protein in experimental and clinical acute lung injury. Am J Respir Crit Care Med 2004;170:1310-1316.
20. Speyer CL, Neff TA, Warner RL, Guo RF, Sarma JV, Riedemann NC, Murphy ME, Murphy HS, Ward PA. Regulatory effects of iNOS on acute lung inflammatory responses in mice. Am J Pathol 2003;163:2319-2328.
21. Levi M, Schultz MJ, Rijneveld AW, van der Poll T. Bronchoalveolar coagulation and fibrinolysis in endotoxemia and pneumonia. Crit Care Med 2003;31:238-242.
22. Ollivier V, Houssaye S, Ternisien C, Leon A, de Verneuil H, Elbim C, Mackman N, Edgington TS, de Prost D. Endotoxin-induced tissue factor messenger RNA in human monocytes is negatively regulated by a cyclic AMP-dependent mechanism. Blood 1993;81:973-979.
23. van der Poll T, Levi M, Dentener M, Jansen PM, Coyle SM, Braxton CC, Buurman WA, Hack CE, ten Cate JW, Lowry SF. Epinephrine exerts anticoagulant effects during human endotoxemia. J Exp Med 1997;185:1143-1148.
24. Maris NA, de Vos AF, Bresser P, van der Zee JS, Jansen HM, Levi M, van der Poll T. Salmeterol enhances pulmonary fibrinolysis in healthy volunteers. Crit Care Med 2007;35:57-63.
25. Morath S, Geyer A, Hartung T. Structure-function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus. J Exp Med 2001;193:393-397.
26. Verheijen JH, Chang GT, Kluft C. Evidence for the occurrence of a fast-acting inhibitor for tissue-type plasminogen activator in human plasma. Thromb Haemost 1984;51:392-395.
27. Verheijen JH, Mullaart E, Chang GT, Kluft C, Wijngaards GA. Simple, sensitive spectrophotometric assay for extrinsic (tissue-type) plasminogen activator applicable to measurements in plasma. Thromb Haemost 1982;48:266-269.
28. Sekut L, Champion BR, Page K, Menius JA Jr, Connolly KM. Antiinflammatory activity of salmeterol: down-regulation of cytokine production. Clin Exp Immunol 1995;99:461-466.
29. Elenkov IJ, Hasko G, Kovacs KJ, Vizi ES. Modulation of lipopolysaccharide-induced tumor necrosis factor-alpha production by selective alpha- and beta-adrenergic drugs in mice. J Neuroimmunol 1995;61:123-131.
30. Pettipher ER, Labasi JM, Salter ED, Stam EJ, Cheng JB, Griffiths RJ. Regulation of tumour necrosis factor production by adrenal hormones in vivo: insights into the antiinflammatory activity of rolipram. Br J Pharmacol 1996;117:1530-1534.
31. Abraham E, Kaneko DJ, Shenkar R. Effects of endogenous and exogenous catecholamines on LPS-induced neutrophil trafficking and activation. Am J Physiol 1999;276:1-8.
32. van der Poll T, Coyle SM, Barbosa K, Braxton CC, Lowry SF. Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia. J Clin Invest 1996;97:713-719.
33. Wu CC, Liao MH, Chen SJ, Chou TC, Chen A, Yen MH. Terbutaline prevents circulatory failure and mitigates mortality in rodents with endotoxemia. Shock 2000;14:60-67.
34. Flierl MA, Rittirsch D, Nadeau BA, Chen AJ, Sarma JV, Zetoune FS, McGuire SR, List RP, Day DE, Hoesel LM, et al. Phagocyte-derived catecholamines enhance acute inflammatory injury. Nature 2007;449:721-725.
35. Arcaroli J, Yang KY, Yum HK, Kupfner J, Pitts TM, Park JS, Strassheim D, Abraham E. Effects of catecholamines on kinase activation in lung neutrophils after hemorrhage or endotoxemia. J Leukoc Biol 2002;72:571-579.
36. McAuley DF, Frank JA, Fang X, Matthay MA. Clinically relevant concentrations of beta2-adrenergic agonists stimulate maximal cyclic adenosine monophosphate-dependent airspace fluid clearance and decrease pulmonary edema in experimental acid-induced lung injury. Crit Care Med 2004;32:1470-1476.
37. Whelan CJ, Johnson M, Vardey CJ. Comparison of the anti-inflammatory properties of formoterol, salbutamol and salmeterol in guinea-pig skin and lung. Br J Pharmacol 1993;110:613-618.
38. Saleh TS, Calixto JB, Medeiros YS. Anti-inflammatory effects of theophylline, cromolyn and salbutamol in a murine model of pleurisy. Br J Pharmacol 1996;118:811-819.
39. van Westerloo DJ, Giebelen IA, Florquin S, Daalhuisen J, Bruno MJ, de Vos AF, Tracey KJ, van der Poll T. The cholinergic anti-inflammatory pathway regulates the host response during septic peritonitis. J Infect Dis 2005;191:2138-2148.
40. Abraham E. Coagulation abnormalities in acute lung injury and sepsis. Am J Respir Cell Mol Biol 2000;22:401-404.